ECG criteria
- Newly developed QRS widening in multiple leads (reference value > 100 ms, extrapolated from TCA data and not independently validated for carbamazepine); there is no universal severity threshold — the trend of widening is what matters
- Tall or terminal R wave in aVR and elevated R/S ratio in aVR — thresholds of ≥ 3 mm and R/S > 0.7 were developed for TCA poisoning and extrapolated to carbamazepine without strict validation; the sign is non-specific
- Right axis deviation combined with QRS widening
- QT/QTc interval prolongation — a less consistent sign that may be overestimated due to QRS widening; with a wide QRS, QTc interpretation should be qualified, and JT/JTc can be used for an approximate assessment of repolarization, although there are no validated thresholds for carbamazepine either
- Sinus tachycardia, or bradycardia and AV blocks of varying degrees in severe intoxication
- Ventricular extrasystoles, ventricular tachycardia, ventricular fibrillation in critical overdose
- The QRS morphology may resemble right bundle branch block due to delayed depolarization, but it does not have to meet its typical criteria
What it looks like on ECG
The main change is a new non-specific QRS widening or intraventricular conduction delay affecting most leads. The morphology may vary: sometimes without typical signs of bundle branch block, sometimes with features resembling right bundle branch block. Widening should be evaluated in comparison with the patient's baseline ECG and in the clinical context, rather than as an isolated rigid criterion. There is no validated QRS duration threshold for carbamazepine that reliably separates mild from severe intoxication: the reference value of > 100 ms as a sign of significant sodium channel blockade, as well as ranges around 120–160 ms as markers of high risk for ventricular arrhythmias, are known primarily from TCA poisoning data and are applied to carbamazepine only with a caveat, without dedicated validation. Clinically significant is a new and/or progressive QRS widening over time rather than a specific threshold number.
Quite frequently, though not necessarily, a tall or terminal R wave in aVR is observed with a deep terminal S in I and aVL, sometimes with an R/S ratio in aVR above 0.7. These numerical thresholds were developed and validated primarily for tricyclic antidepressant poisoning; in carbamazepine toxicity, they are used as a possible, but non-specific reference point rather than an independent diagnostic criterion.
The QT/QTc interval may appear prolonged, but this is a less consistent finding than QRS widening, and the measured QTc may be overestimated simply due to increased depolarization duration — with a wide QRS, QTc interpretation is limited. As an approximate alternative, repolarization can be assessed using JT/JTc, but there are no specific validated JT/JTc thresholds for carbamazepine poisoning. In severe intoxication, sinus bradycardia, AV block of varying degrees (first-, second-, up to complete), and ventricular arrhythmias ranging from isolated extrasystoles to polymorphic ventricular tachycardia and ventricular fibrillation are possible.
| Parameter | Parameter |
|---|---|
| QRS | new widening, reference > 100 ms; no validated severity threshold for carbamazepine |
| R in aVR | may be tall; TCA thresholds (≥ 3 mm, R/S > 0.7) are non-specific for carbamazepine |
| QTc | may appear prolonged, partially due to QRS widening; JT/JTc is an approximate alternative without validated thresholds |
| Rhythm | tachycardia is more frequent; bradycardia/AV block in severe cases |
| Ventricular arrhythmias | possible at high doses |
Blood concentrations of carbamazepine may correlate poorly with the severity of a particular patient's condition, so the physician relies on the clinical picture and serial ECG monitoring; drug concentration is evaluated as an additional parameter rather than contrasted with QRS width.
Mechanism
Carbamazepine blocks fast voltage-gated sodium channels of cardiomyocytes and, at toxic concentrations, slows intraventricular conduction. Functionally, this resembles the action of certain class I antiarrhythmics and tricyclic antidepressants, although carbamazepine belongs to neither TCAs nor these antiarrhythmic classes — it is described as a tricyclic anticonvulsant with a membrane-stabilizing effect.
Slowing of phase 0 of the action potential and conduction through the His-Purkinje system can alter the sequence and direction of the terminal depolarization vector, forming rightward-directed terminal forces, including a tall R in aVR. This reflects the slowing and shift of terminal depolarization rather than proven selective sodium channel blockade of the right ventricle alone. The slowing and heterogeneity of intraventricular conduction can create conditions for re-entry and ventricular arrhythmias, while simultaneously causing suppression of sinus and AV node automaticity and AV conduction disturbances; concomitant autonomic regulation disorders also contribute.
Causes
- Acute carbamazepine overdose (suicidal or accidental)
- Chronic intoxication due to impaired metabolism — liver failure and CYP3A4 inhibition increase drug concentrations
- Overdose in combination with other sodium channel blockers (TCAs, certain antiarrhythmics), which enhances the effect
- Renal failure — since the drug is metabolized mainly in the liver, renal failure has little direct impact on parent drug clearance, but it may alter active metabolite levels and overall toxicity
Differential diagnosis
Tricyclic antidepressant poisoning — a similar ECG pattern (QRS widening, possible tall R in aVR) due to a similar mechanism of sodium channel blockade; differentiated by the history of drug ingestion and toxicological analysis, as the ECG pattern itself is non-specific.
Poisoning by other sodium channel blockers (certain antiarrhythmics, cocaine) — identical electrophysiology, differentiation also based on clinical and anamnestic data.
Organic right bundle branch block — in toxic widening, QRS morphology may not meet the typical criteria of true bundle branch block (RSR' in V1, wide S in I and V6) and tends to be more uniform; definitively differentiated using the baseline ECG and clinical findings.
Hyperkalemia — also widens the QRS and may be accompanied by tall peaked T waves and shortening or disappearance of the P wave, although in severe hyperkalemia the T wave may not be prominent; immediate potassium level determination is required if clinically suspected.
Clinical significance and management
New intraventricular conduction delay on the ECG raises suspicion for carbamazepine cardiotoxicity and requires serial ECG recordings and rhythm monitoring in a setting that allows continuous observation and readiness for resuscitation. A reliable linear relationship between QRS width and the risk of cardiac arrest has not been established for carbamazepine, so decisions regarding the intensity of monitoring are based not only on QRS width, but also on the level of consciousness, respiration, hemodynamics, presence of seizures, drug concentration, and concomitant medications or toxicants.
In cases of significant or progressive QRS widening, ventricular arrhythmias, and/or hypotension, sodium bicarbonate may be administered according to toxicological protocols — as a bolus or infusion, with monitoring of pH, sodium, potassium levels, and signs of volume overload. The evidence base for this approach in carbamazepine is weaker than for TCAs, and universal indications and regimens are less clear-cut; the decision on specific therapy is made by a toxicologist/intensivist.
It is important for the functional diagnostics physician to record QRS width, the presence of a tall R in aVR, QTc, and rhythm dynamics — this serves as an objective reference point for evaluating the patient's condition in combination with clinical and laboratory data, rather than an independent metric that replaces other observations.
Common interpretation errors
- Interpreting widened QRS as organic bundle branch block without considering the clinical context (history of drug ingestion)
- Overestimating a tall R in aVR as a specific and sufficient criterion for carbamazepine intoxication, whereas its thresholds were validated primarily for TCAs
- Perceiving QRS width ranges known from TCAs as strictly validated for carbamazepine as well
- Focusing solely on blood drug concentrations without accounting for ECG dynamics across a series of recordings
- Missing bradyarrhythmias and AV blocks while focusing solely on QRS widening
1. Which ECG sign is most characteristic of carbamazepine cardiotoxicity?
Fast sodium channel blockade slows ventricular depolarization, which manifests as new QRS widening; a tall R wave in aVR may accompany this, but is neither specific nor mandatory.
2. The ECG picture of carbamazepine intoxication resembles which drug in its mechanism of cardiotoxicity?
Both drugs block myocardial fast sodium channels, producing a functionally similar QRS widening and a possible tall R wave in aVR.
3. How is it best to assess the severity of carbamazepine cardiotoxicity in practice?
Serial QRS width helps assess toxic conduction delay and its dynamics, whereas carbamazepine concentration does not always strictly reflect severity; both parameters are interpreted together with the clinical picture.
Frequently asked questions
How does the ECG in carbamazepine poisoning differ from TCA poisoning?
Electrophysiologically and on the ECG, the picture can be similar—QRS widening, possible tall R wave in aVR—since both drugs block sodium channels in a similar manner. At the same time, numerical thresholds for aVR and QRS width are validated primarily for TCAs. The cause can be distinguished only by the history of drug ingestion and toxicological analysis, not by the ECG alone.
What QRS width is dangerous in carbamazepine intoxication?
There is no universally accepted and validated QRS width threshold specifically for carbamazepine. A width of > 100 ms is conventionally considered a marker of significant sodium channel blockade, while ranges around 120–160 ms as a marker of high risk for ventricular arrhythmias are described for TCAs and applied to carbamazepine with reservation. In practice, new and/or progressive QRS widening over time is more important, and tactical decisions rely on the overall clinical picture.
Is the QT interval prolonged in carbamazepine cardiotoxicity?
QT/QTc may appear prolonged, but this is a less constant and less specific sign than QRS widening, and its increase may be partly related to the QRS widening itself. JT/JTc is sometimes used as a rough alternative for assessing repolarization in the presence of a wide QRS, but there are no validated thresholds for it specifically for carbamazepine. The main indicator of severity remains the QRS complex width and the overall clinical picture.
Why does a tall R wave appear in aVR?
Intraventricular conduction delay during sodium channel blockade can shift the terminal part of ventricular depolarization toward the right shoulder, which is why a tall terminal R wave is sometimes registered in aVR, and a deep terminal S wave in I and aVL. This is a non-specific sign rather than proven selective right ventricular block.
What is the physician's tactic when QRS widens during carbamazepine therapy?
Continuous rhythm monitoring, serial assessment of QRS width and QTc over time, readiness to treat ventricular arrhythmias and AV blocks, and transfer to an intensive care unit in case of worsening changes or clinical deterioration are required. Specific pharmacotherapy, including the possible use of sodium bicarbonate for significant QRS widening, ventricular arrhythmias, and/or hypotension, is determined by a toxicologist/intensivist according to current protocols.
ECG Course
Interpretation from basics to myocardial infarction — learn to read any ECG using a systematic algorithm.
- Video lessons and theory for every topic
- Simulator case studies under every lesson
- Unlimited ECG simulator practice
- Study guide: "All ECGs in 25 minutes"
ECG Strip Simulator
ECG, radiology, histology, pathomorphology, pharmacology — thousands of flashcards with detailed explanations.
- Real ECG strips, not textbook drawings
- Instant answers and explanations
- Streaks and progress tracking in your dashboard
Related terms
More in "Pharmacology and Toxicology"
Sources
- Goldberger A. Clinical Electrocardiography: A Simplified Approach
- Surawicz B., Knilans T. Chou's Electrocardiography in Clinical Practice
- Orlov V.N. Guide to Electrocardiography
Educational material for medical students and physicians. Does not replace clinical guidelines and physical examination; the ECG must always be interpreted in conjunction with the clinical picture.